Relay Technology Management Announces Pipeline-by-Pathway Target Searching to Enable Biologically-Based Business Intelligence for the Pharmaceutical Industry
(Marketwire Via Acquire Media NewsEdge) CAMBRIDGE, MA -- (Marketwire) -- 12/18/12 --
Relay Technology Management Inc. is pleased to announce the release of the pipeline-by-pathway target searching module as part of version 1.2 of Business Development Live!, Relay's flagship real-time comparative asset analysis and trend analytics software-as-a-service for the life sciences industry. From protein sequences to inhibitor connections, BD Live! enables life sciences professionals to access the largest real-time database of company-target-drug relationships and access rich data on industry trends.
"We wanted to provide our customers with a tool that enabled them to look at competitive intelligence at the molecular level," says Dr. David Greenwald, Managing Director and Co-Founder of Relay. "Now, users of BD Live! have the capability to search by molecular target of interest in order to identify the competitive landscape, not only at the pipeline level but within patents and publications. All associations are backed up by existing aspects of BD Live!, including source document transparency and live daily updates."
Relay's BD Live! system is built upon an ontologically-driven text mining approach that leverages real time data from an ever-expanding set of sources to establish data-driven, transparent relationships within scientific, clinical, and industry data. The pipeline-by-pathway target searching module enables business professionals in life science and biopharmaceutical firms to interact with competitive intelligence data and transactional information on a biologic basis. The user can move seamlessly from therapeutic hypothesis through to asset identification and benchmarking in one simple process.
The software platform which powers BD Live!, The Relay Innovation Engine, indexes over 100 million documents, and categorizes over 38,000 drugs, 16,000 companies, and 37,000 drug targets and genes. In addition to its standard set of data visualizations and analytics offered to all users, Relay's suite of customizable dashboards enables us to deploy solutions that are highly customized to each client's needs. The pipeline-by-pathway module has established over 5,000 unique data driven drug-target relationships within clinical and approved drugs.
About Relay Technology ManagementRelay Technology Management (http://www.relaytm.com) is a life sciences business intelligence and asset comparison software provider. The company's Relay Innovation Engine software platform powers BD Live! to support business development and corporate strategy professionals in the life science industry confirm the attractiveness of assets under consideration and unearth new technologies. Relay aims to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics.
Follow Relay Technology Management on the Relay blog, Twitter, LinkedIn, and Facebook.
Relay Technology Management, Inc.
Email: Email Contact
Source: Relay Technology Management
[ Back To CaaS Homepage's Homepage ]